Lista de obras - Heidi E Drummer - Dominio Público Uruguay

10th Lorne Infection and Immunity Conference 2020

artículo científico publicado en 2020

A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry

artículo científico publicado en 2006

A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81.

artículo científico publicado en 2017

A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus

artículo científico publicado en 2007

A study of the advantages and limitations of immunoblotting procedures for the detection of antibodies against influenza virus.

artículo científico publicado en 1993

A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses

artículo científico publicado en 2014

A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1

artículo científico publicado en 1995

Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity

artículo científico publicado en 2013

An N-terminal glycine-rich sequence contributes to retrovirus trimer of hairpins stability.

artículo científico publicado en 2007

An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry

artículo científico publicado en 2016

Analysis of equine herpesvirus 2 strain variation using monoclonal antibodies to glyucoprotein B.

artículo científico publicado en 2000

Antibodies to the high-density lipoprotein receptor SR-B1 potently inhibit hepatitis C virus replication in vivo: New avenues for preventing reinfection of the liver following transplantation

artículo científico publicado en 2014

Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.

artículo científico publicado en 2018

Application of an equine herpesvirus 1 (EHV1) type-specific ELISA to the management of an outbreak of EHV1 abortion

artículo científico publicado en 1995

B cell immunodominance in primary hepatitis C virus infection

scientific article published on 28 November 2019

Calsyntenin-1 mediates hepatitis C virus replication

artículo científico publicado en 2016

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

artículo científico publicado en 2003

Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies

artículo científico publicado en 2014

Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line

artículo científico publicado en 2016

Characterization of glycoprotein B of the gammaherpesvirus equine herpesvirus-2.

artículo científico publicado en 1998

Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.

artículo científico publicado en 1989

Claudin association with CD81 defines hepatitis C virus entry.

artículo científico publicado en 2010

Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting

artículo científico publicado en 2019

Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus

artículo científico publicado en 1994

Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix

artículo científico publicado en 2009

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users

artículo científico publicado en 2014

Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.

artículo científico publicado en 2005

Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion

artículo científico publicado en 2018

Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.

artículo científico publicado en 2012

Editorial on "Broadly neutralizing antibodies abrogate established hepatitis C virus infection" published in Science Translational Medicine on 17th September 2014

artículo científico publicado en 2015

Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine

artículo científico publicado en 2020

Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals

artículo científico publicado en 1999

Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes

scientific article published on 01 January 1996

Equine herpesvirus-4 glycoprotein G is secreted as a disulphide-linked homodimer and is present as two homodimeric species in the virion

artículo científico publicado en 1998

Equine rhinitis A virus: structural proteins and immune response

artículo científico publicado en 2001

Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.

artículo científico publicado en 2018

Evidence of CD4+ T cell-mediated immune pressure on the Hepatitis C virus genome.

artículo científico publicado en 2018

Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.

artículo científico publicado en 2006

Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding

artículo científico publicado en 2007

Expression and biochemical analysis of the entire HIV-2 gp41 ectodomain: determinants of stability map to N- and C-terminal sequences outside the 6-helix bundle core.

artículo científico publicado en 2004

Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41

artículo científico publicado en 2013

Functional evolution of the HIV-1 envelope glycoprotein 120 association site of glycoprotein 41.

artículo científico publicado en 2003

Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion

artículo científico publicado en 2007

Glycosylation of a synthetic peptide representing a T-cell determinant of influenza virus hemagglutinin results in loss of recognition by CD4+ T-cell clones.

artículo científico publicado en 1994

HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.

artículo científico publicado en 2016

Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry

artículo científico publicado en 2011

Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry

artículo científico publicado en 2004

Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis

artículo científico publicado en 2012

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users

artículo científico publicado en 2008

High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.

artículo científico publicado en 2013

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

artículo científico publicado en 2008

Identification of equine herpesvirus 3 (equine coital exanthema virus), equine gammaherpesviruses 2 and 5, equine adenoviruses 1 and 2, equine arteritis virus and equine rhinitis A virus by polymerase chain reaction

artículo científico publicado en 2001

Identification of equine herpesviruses 1 and 4 by polymerase chain reaction

artículo científico publicado en 2001

Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses

artículo científico publicado en 1997

Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production

artículo científico publicado en 2012

Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81

artículo científico publicado en 2002

Identification, sequence analysis and characterisation of equine herpesvirus 5 glycoprotein B.

artículo científico publicado en 1999

Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.

artículo científico publicado en 2007

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.

artículo científico publicado en 2018

In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface

artículo científico publicado en 2012

Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes

artículo científico publicado en 2007

Infectious KoRV-related retroviruses circulating in Australian bats

scientific article published on 13 April 2020

Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection

artículo científico publicado en 2015

Modulation of CD4+ T-Cell Recognition of Influenza Hemagglutinin by Carbohydrate Side Chains Located Outside a T-Cell Determinant

artículo científico publicado en 1993

Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region

artículo científico publicado en 2015

Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1.

artículo científico publicado en 2007

Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin

artículo científico publicado en 2007

Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery

scientific article published on 25 June 2019

Role for the disulfide-bonded region of human immunodeficiency virus type 1 gp41 in receptor-triggered activation of membrane fusion function

artículo científico publicado en 2010

Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusion

artículo científico publicado en 2011

Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function

artículo científico publicado en 2012

Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus

artículo científico publicado en 2001

Seroprevalence of equine herpesvirus 1 in Thoroughbred foals before and after weaning

scientific article published on 01 October 1998

TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus

artículo científico publicado en 2009

The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?

artículo científico publicado en 2016

The SR-BI partner PDZK1 facilitates hepatitis C virus entry.

artículo científico publicado en 2010

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination

scientific article published on 18 September 2019

The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs

artículo científico publicado en 2016

The global threat of Zika virus to pregnancy: epidemiology, clinical perspectives, mechanisms, and impact

artículo científico publicado en 2016

The nucleotide sequence of the glycoprotein G homologue of equine herpesvirus 3 (EHV3) indicates EHV3 is a distinct equid alphaherpesvirus

artículo científico publicado en 1999

The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments

artículo científico publicado en 2015

The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity

artículo científico publicado en 2010

Transient and stable expression of the HCV envelope glycoproteins in cell lines and primary hepatocytes transduced with a recombinant baculovirus

artículo científico publicado en 2006

Lista de obras de Heidi E Drummer

10th Lorne Infection and Immunity Conference 2020

A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry

A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81.

A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus

A study of the advantages and limitations of immunoblotting procedures for the detection of antibodies against influenza virus.

A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses

A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1

Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity

An N-terminal glycine-rich sequence contributes to retrovirus trimer of hairpins stability.

An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry

Analysis of equine herpesvirus 2 strain variation using monoclonal antibodies to glyucoprotein B.

Antibodies to the high-density lipoprotein receptor SR-B1 potently inhibit hepatitis C virus replication in vivo: New avenues for preventing reinfection of the liver following transplantation

Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.

Application of an equine herpesvirus 1 (EHV1) type-specific ELISA to the management of an outbreak of EHV1 abortion

B cell immunodominance in primary hepatitis C virus infection

Calsyntenin-1 mediates hepatitis C virus replication

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies

Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line

Characterization of glycoprotein B of the gammaherpesvirus equine herpesvirus-2.

Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.

Claudin association with CD81 defines hepatitis C virus entry.

Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting

Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus

Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users

Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.

Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion

Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.

Editorial on "Broadly neutralizing antibodies abrogate established hepatitis C virus infection" published in Science Translational Medicine on 17th September 2014

Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine

Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals

Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes

Equine herpesvirus-4 glycoprotein G is secreted as a disulphide-linked homodimer and is present as two homodimeric species in the virion

Equine rhinitis A virus: structural proteins and immune response

Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.

Evidence of CD4+ T cell-mediated immune pressure on the Hepatitis C virus genome.

Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.

Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding

Expression and biochemical analysis of the entire HIV-2 gp41 ectodomain: determinants of stability map to N- and C-terminal sequences outside the 6-helix bundle core.

Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41

Functional evolution of the HIV-1 envelope glycoprotein 120 association site of glycoprotein 41.

Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion

Glycosylation of a synthetic peptide representing a T-cell determinant of influenza virus hemagglutinin results in loss of recognition by CD4+ T-cell clones.

HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.

Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry

Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry

Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users

High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

Identification of equine herpesvirus 3 (equine coital exanthema virus), equine gammaherpesviruses 2 and 5, equine adenoviruses 1 and 2, equine arteritis virus and equine rhinitis A virus by polymerase chain reaction

Identification of equine herpesviruses 1 and 4 by polymerase chain reaction

Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses

Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production

Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81

Identification, sequence analysis and characterisation of equine herpesvirus 5 glycoprotein B.

Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.

In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface

Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes

Infectious KoRV-related retroviruses circulating in Australian bats

Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection

Modulation of CD4+ T-Cell Recognition of Influenza Hemagglutinin by Carbohydrate Side Chains Located Outside a T-Cell Determinant

Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region

Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1.

Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin

Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery

Role for the disulfide-bonded region of human immunodeficiency virus type 1 gp41 in receptor-triggered activation of membrane fusion function

Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusion

Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function

Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus

Seroprevalence of equine herpesvirus 1 in Thoroughbred foals before and after weaning

TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus

The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?

The SR-BI partner PDZK1 facilitates hepatitis C virus entry.

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination

The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs

The global threat of Zika virus to pregnancy: epidemiology, clinical perspectives, mechanisms, and impact